Evidence map›Paper›PMID 38006943›Full record

ArticleKidney international2024

Evaluation of novel candidate filtration markers from a global metabolomic discovery for glomerular filtration rate estimation.

Nora F Fino, Ogechi M Adingwupu, Josef Coresh, Tom Greene, Ben Haaland, Michael G Shlipak, Veronica T Costa E Silva, Roberto Kalil, Ayse L Mindikoglu, Susan L Furth and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Kidney international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00327860 (Chronic Kidney Disease in Children Prospective Cohort Study), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00327860 recruitingnot on this map

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2003 to 2028Enrolled1,300ConditionsChronic Kidney Disease
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Nora F FinoDivision of Biostatistics, Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.
Ogechi M AdingwupuDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
Josef CoreshDepartment of Population Health, NYU Langone, New York, New York, USA.
Tom GreeneDivision of Biostatistics, Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.
Ben HaalandDivision of Biostatistics, Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.
Michael G ShlipakKidney Health Research Collaborative, San Francisco Veterans Affair Medical Center and University of California, San Francisco, San Francisco, California, USA.
Veronica T Costa E SilvaServiço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Laboratório de Investigação Médica 16, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Roberto KalilDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ayse L MindikogluMargaret M. and Albert B. Alkek Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA; Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas, USA.
Susan L FurthDepartment of Pediatrics, Children's Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jesse C SeegmillerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Andrew S LeveyDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
Lesley A InkerDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA. Electronic address: linker@tuftsmedicalcenter.org.

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Chronic Kidney Disease in Children Study (C-Kid)U01DK066174 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SUSAN L. FURTH · 2003 to 2026
$25.1M
CKiD Cardiovascular Testing Travel SupplementU01DK066143 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Bradley Alan Warady · 2003 to 2026
$24.2M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)U24DK066116 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Derek K Ng · 2018 to 2026
$12.6M
Improving Kidney Function Assessment in Health and DiseaseR01DK116790 · NIDDK · TUFTS MEDICAL CENTER · PI INKER, LESLEY ANN · 2021 to 2024
$2.9M
Gender Disparity in Liver TransplantationK23DK089008 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MINDIKOGLU, AYSE LEYLA · 2010 to 2014
$896k
NCATS NIH HHS UM1 TR004409NIDDK NIH HHS K23 DK089008NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK116790NIDDK NIH HHS U01 DK066143NIDDK NIH HHS U01 DK066174NIDDK NIH HHS U24 DK066116
6 · The paper itself

Abstract

Creatinine and cystatin-C are recommended for estimating glomerular filtration rate (eGFR) but accuracy is suboptimal. Here, using untargeted metabolomics data, we sought to identify candidate filtration markers for a new targeted assay using a novel approach based on their maximal joint association with measured GFR (mGFR) and with flexibility to consider their biological properties. We analyzed metabolites measured in seven diverse studies encompasing 2,851 participants on the Metabolon H4 platform that had Pearson correlations with log mGFR and used a stepwise approach to develop models to < -0.5 estimate mGFR with and without inclusion of creatinine that enabled selection of candidate markers. In total, 456 identified metabolites were present in all studies, and 36 had correlations with mGFR < -0.5. A total of 2,225 models were developed that included these metabolites; all with lower root mean square errors and smaller coefficients for demographic variables compared to estimates using untargeted creatinine. Seventeen metabolites were chosen, including 12 new candidate filtration markers. The selected metabolites had strong associations with mGFR and little dependence on demographic factors. Candidate metabolites were identified with maximal joint association with mGFR and minimal dependence on demographic variables across many varied clinical settings. These metabolites are excreted in urine and represent diverse metabolic pathways and tubular handling. Thus, our data can be used to select metabolites for a multi-analyte eGFR determination assay using mass spectrometry that potentially offers better accuracy and is less prone to non-GFR determinants than the current eGFR biomarkers.

Indexed as

MetabolomicsRenal Insufficiency, ChronicBiomarkersCreatinineGlomerular Filtration RateHumansBiomarkersCreatininefiltration markersglomerular filtration ratemetabolomics

Identifiers

PMID38006943
PMCPMC10932836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.